编者按：第 11 届亚太人类遗传学大会（APCHG 2015）于 9 月 16-18 日在越南河内顺利召开。本次大会上， 400 份 AME 旗下 Annals of Translational Medicine（简称 ATM）杂志会议专辑，800 份 Translational Pediatrics（简称TP）杂志两期特刊宣传页被放入会议资料包，送达到 400 余位参会人员的手中。会议期间，小编有幸邀请到大会讲者，来自耶鲁大学的 Vasilis Vasiliou 教授分享他的研究，以及他科研之路上的小故事。
We notice that you have given a speech on “aldehyde dehydrogenases: from cancer stem cells to inborn errors of metabolism”. It’s really impressive and comprehensive. Could you give us a general picture of the role of ALDH in metabolism?
Why did you choose to study ALDH at the beginning, as there are so many enzymes? Is there any story here?
You have led and participated in a lot of international collaboration. What do you think is the biggest challenge during the collaboration?
Finally could you share with us the most impressive points for you of this year’s APCHG?
受访专家|Vasilis Vasiliou is Professor and Chair of the Department of Environmental Health Sciences. In July 2014, he joined the faculty of Yale University in his new position. Professor Vasiliou has established an internationally-recognized research program that has been continuously funded by NEI/NIH and NIAAA/NIH since 1997. His research interests include mechanisms of cellular responses to environmental stress, gene environment interactions, alcohol toxicity, pharmacogenetics and the evolution of gene families. His research focuses on the role of aldehyde dehydrogenases, cytochrome P-450s and glutathione in metabolism and disease (specifically, alcohol-induced tissue injury, diabetes, gout and cancer). Dr. Vasiliou has published over 150 papers and edited two books on Alcohol and Cancer. He has trained over twenty doctoral and post-doctoral students. Dr. Vasiliou is the editor of Human Genomics and serves on the editorial boards of several toxicology and visual sciences journals.
点击链接，查看AME旗下 Translational Pediatrics 杂志“Studieson Genetic Diseases for better therapies in Pediatrics”特刊。http://www.thetp.org/issue/view/297